Pharma Pulse 6/21/24: Global Mortality and Disability from Type 1 Diabetes Have Decreased, What Leaders of Effective Teams Know & more
What the Leaders of the Most Effective Teams Know
Findings from hundreds of interviews of exceptional pharma leaders around the world.
Global Mortality and Disability from Type 1 Diabetes Have Decreased
Global mortality fell 13 times faster in countries with a high sociodemographic index compared with countries with a low-middle sociodemographic index.
Improve Site Experience with Data-Driven Protocol Design
Do you know what challenges are encountered by sites when operationalizing study protocols? In this webinar, learn how specific protocol design elements impact sites’ perception of burden and how this information can be used to improve site experience.
South Africa Runs Out of Insulin Pens as Global Supply Shifts to Weight-Loss Drugs
The shortage highlights a widening gulf in the standard of care for people with diabetes, most of whom live in low-income countries.
QPS Announces New Global Clinical Research Operations Leadership
QPS is pleased to announce new clinical research operations leadership. This new clinical leadership will further align the existing global medical affairs, regulatory affairs, data services, and clinical operations units with the existing successful QPS Phase I clinics. The enhanced global capabilities will help QPS satisfy the need for agility, flexibility, and speed in the quickly evolving global drug development community.
Explore the latest from Pierantonio Russo MD, FCPP, FAAP, STS, Chief Medical Officer at EVERSANA on the importance of tailored interventions in overcoming healthcare disparities and improving medication adherence. Dive into his insights in Pharmaceutical Commerce Magazine and learn how addressing social determinants of health can lead to better patient outcomes.
https://lnkd.in/gkxCfxst
#HealthcareInnovation #Adherence #PatientCare
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
